Clinical Trials (PDQ®) - National Cancer Institute

Page Options

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights

ZD4054 in Pain-free or Mildly Symptomatic Patients with Prostate Cancer and Bone Metastases who have Rising Serum Prostate Specific Antigen (PSA)

Basic Trial Information
Trial Description
Summary
Eligibility Criteria
Trial Contact Information

Basic Trial Information

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase II

Treatment

Active

18 and over

Pharmaceutical / Industry

D4320C00006
Trial 6, ZD4054, NCT00090363

Trial Description

Summary

Randomized, double-blind, parallel-group, placebo-controlled, multi-centre study to assess ZD4054 in pain-free or mildly symptomatic patient with prostate cancer and bone metastases who have rising serum prostate specific antigen (PSA)

Eligibility Criteria

Inclusion Criteria:

Surgically or medically castrated
Bone metastasis
Rising PSA

Exclusion Criteria:

Opiate use
Prior chemotherapy

Trial Contact Information

Trial Lead Organizations/Sponsors

AstraZeneca Pharmaceuticals LP

AstraZeneca Information Center (8 AM – 7 PM EST)

Ph: 1-800-236-9933

Trial Sites

U.S.A.

Arizona

Gleason

Research Site

Tucson

Research Site

California

Los Angeles

Research Site

Illinois

Chicago

Research Site

Chodak

Research Site

Maryland

Baltimore

Research Site

Ohio

Cleveland

Research Site

Link to the current ClinicalTrials.gov record.
NLM Identifer NCT00090363
Information obtained from ClinicalTrials.gov on 2005-02-24

Note: Information about this trial is from the ClinicalTrials.gov database. The versions designated for health professionals and patients contain the same text. Minor changes may be made to the ClinicalTrials.gov record to standardize the names of study sponsors, sites, and contacts. Cancer.gov only lists sites that are recruiting patients for active trials, whereas ClinicalTrials.gov lists all sites for all trials. Questions and comments regarding the presented information should be directed to ClinicalTrials.gov.